Generation Bio Co. (GBIO)
NASDAQ: GBIO · Real-Time Price · USD
5.51
+0.01 (0.18%)
At close: Oct 31, 2025, 4:00 PM EDT
5.60
+0.09 (1.63%)
After-hours: Oct 31, 2025, 6:26 PM EDT
Generation Bio Co. Market Cap
Generation Bio Co. has a market cap or net worth of $37.11 million as of October 31, 2025. Its market cap has decreased by -77.40% in one year.
Market Cap
37.11M
Enterprise Value
-18.93M
1-Year Change
-77.40%
Ranking
Category
Stock Price
$5.51
Market Cap Chart
Since June 12, 2020, Generation Bio Co.'s market cap has decreased from $1.07B to $37.11M, a decrease of -96.54%. That is a compound annual growth rate of -46.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 37.11M | -47.58% |
| Dec 31, 2024 | 70.80M | -35.06% |
| Dec 29, 2023 | 109.03M | -53.31% |
| Dec 30, 2022 | 233.53M | -41.89% |
| Dec 31, 2021 | 401.89M | -68.88% |
| Dec 31, 2020 | 1.29B | 20.54% |
| Jun 12, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 772.59B |
| Johnson & Johnson | 455.04B |
| AbbVie | 385.18B |
| UnitedHealth Group | 309.40B |
| AstraZeneca | 253.98B |
| Novartis AG | 237.13B |
| Novo Nordisk | 216.87B |
| Abbott Laboratories | 214.96B |